SCHEMBL29623469

SCHEMBL29623469

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC1CCN(CC(N)=O)CC1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 12/20 0.84
EGFR P00533 13/20 0.79
EPHB4 P54760 2/20 0.63
AURKA O14965 1/20 0.63
INSR P06213 1/20 0.63
FBP1 P09467 1/20 0.63
PDGFRB P09619 1/20 0.63
FLT4 P35916 1/20 0.63
KDR P35968 1/20 0.63
CLK1 P49759 1/20 0.63
TEK Q02763 1/20 0.63
AURKB Q96GD4 1/20 0.63
GAK O14976 1/20 0.63
RIPK2 O43353 1/20 0.63
LYN P07948 1/20 0.63
RET P07949 1/20 0.63
EPHA1 P21709 1/20 0.63
ERBB3 P21860 1/20 0.63
EPHA2 P29317 1/20 0.63
EPHB2 P29323 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL185530 1.00 ERBB2 (0.84) ERBB2EGFREPHB4AURKAINSR
SCHEMBL1920505 0.94 ERBB2 (0.75) ERBB2EGFRGAKRIPK2RIPK3
SCHEMBL24637510 0.93 ERBB2 (0.86) ERBB2EGFREPHB4AURKAINSR
SCHEMBL4885366 0.92 ERBB2 (1.00) ERBB2EGFREPHB4AURKAINSR
SCHEMBL1331718 0.91 ERBB2 (0.82) ERBB2EGFREPHB4AURKAINSR
SCHEMBL24637201 0.91 ERBB2 (0.82) ERBB2EGFREPHB4AURKAINSR
SCHEMBL4879883 0.90 ERBB2 (0.81) ERBB2EGFREPHB4AURKAINSR
SCHEMBL12743207 0.90 EGFR (0.79) ERBB2EGFREPHB4AURKAINSR
SCHEMBL29623426 0.89 EGFR (0.82) ERBB2EGFREPHB4AURKAINSR
SCHEMBL118379 0.89 EGFR (0.82) ERBB2EGFREPHB4AURKAINSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110840847-B Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases 沃泰克斯药物股份有限公司 2022-07-29 CN disclosed
CN-110713489-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-05-31 CN disclosed
CN-110183440-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-04-22 CN disclosed